Oral immunogenicity of human papillomavirus-like particles expressed in potato.
Ontology highlight
ABSTRACT: Human papillomavirus-like particles (HPV VLPs) have shown considerable promise as a parenteral vaccine for the prevention of cervical cancer and its precursor lesions. Parenteral vaccines are expensive to produce and deliver, however, and therefore are not optimal for use in resource-poor settings, where most cervical HPV disease occurs. Transgenic plants expressing recombinant vaccine immunogens offer an attractive and potentially inexpensive alternative to vaccination by injection. For example, edible plants can be grown locally and can be distributed easily without special training or equipment. To assess the feasibility of an HPV VLP-based edible vaccine, in this study we synthesized a plant codon-optimized version of the HPV type 11 (HPV11) L1 major capsid protein coding sequence and
SUBMITTER: Warzecha H
PROVIDER: S-EPMC167207 | biostudies-literature | 2003 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA